Trial Profile
Randomized,Open Label,Balanced,Two Treatment, Four Period, Two Sequence, Single Oral Dose, Crossover, Replicate Study Under Fasting Conditions to Test Within Subject Variability of 20mg ER Torsemide and Demadex Tablets in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2018
Price :
$35
*
At a glance
- Drugs Torasemide (Primary)
- Indications Oedema
- Focus Pharmacokinetics
- Sponsors Sarfez Pharmaceuticals
- 17 Apr 2018 Status changed from recruiting to completed.
- 14 Jul 2017 New trial record